Furthermore, in co-culture experiments of iDCs with a panel of EpCAM+ cancer cell lines, treatment with anti-EpCAM:CD40L induced significant IL-12 production that was inhibited by the EpCAM blocking antibody (Figure 4C). The gene discussed is CD40LG; the disease is cancer.